About Galt Pharmaceuticals Franchise
Galt Pharmaceuticals is a healthcare franchise operating under Galt Companies, LLC that has been offering franchise opportunities since 2018.
The brand works in the pharmaceutical compounding and specialty medication space, providing customized pharmaceutical solutions for patients and healthcare providers.
The franchise fee is $200,000, reflecting the specialized nature and high revenue potential of the pharmaceutical industry.
Galt Pharmaceuticals Franchise Cost & Fees
Minimum Investment
$220K
Average Investment
$231K
Maximum Investment
$242K
| Fee Type | Amount | Notes |
|---|---|---|
| Initial Franchise Fee | $200,000 | One-time payment upon signing |
| Royalty Fee | 6% of your Total Sales Margins of gross sales | Ongoing; paid monthly |
| Marketing/Ad Fund | 1% of Total Sales Margins | National brand fund |
| Total Investment Range | $219,950 – $242,200 | Includes build-out, inventory, working capital |
The investment range of $220K–$242K reflects variability in build-out costs, store size, lease terms, and market. The combined royalty (6% of your Total Sales Margins) and marketing fee (1% of Total Sales Margins) are ongoing costs paid as a percentage of gross sales.
Investment Breakdown (Item 7)
| Item | Low | High |
|---|---|---|
| Initial franchise fee (see note 1) | $200,000 | $200,000 |
| Rent, Utilities, and Leasehold Improvements (see Note 2) | $0 | $0 |
| Furniture, Fixtures, and Equipment | $0 | $500 |
| Computer Systems (see Note 3) | $1,700 | $3,200 |
| Insurance (see Note 4) | $1,250 | $2,500 |
| Vehicle (see Note 5) | $0 | $3,500 |
| Office Expenses (see Note 6) | $0 | $500 |
| Samples (see Note 7) | $500 | $5,000 |
| Market Introduction Plan, including Marketing Materials (see Note 8) | $0 | $1,000 |
| Licenses and Permits (see Note 9) | $0 | $1,000 |
| Professional Fees (lawyer, accountant, etc.) | $500 | $2,000 |
| Travel, lodging and meals for initial training | $1,000 | $3,000 |
| Additional funds (for first 3 months) (see Note 10) | $15,000 | $20,000 |
Additional Fees (Item 6)
| Fee Type | Amount |
|---|---|
| Transfer Fee | $25,000, plus any broker fees and other out-of-pocket costs we incur |
| Renewal Fee | One-half of our then-current initial franchise fee |
| Technology Fee | Currently, $700 per year per user |
| Audit Fee | Our actual cost |
| Medical and Scientific Affairs Support Fee | 2% of your Total Sales Margins |
| Data Targeting and Reporting Fee | 2% of Total Sales Margins |
| Replacement / Additional Training fee | Currently, $750 per day |
| Non-compliance fee | $500 (and $250 per week thereafter) |
| Reimbursement | Amount that we spend on your behalf, plus 10% |
| Late fee | $100 plus interest on the unpaid amount at a rate equal to 18% per year |
| Insufficient funds fee | $30 |
| Costs of collection | Our actual costs |
| Breach of territory fee | The greater of (i) $500 or (ii) 75% of the amount paid by the customer outside of your territory |
| Special support fee | Our then-current fee, plus our expenses. Currently, $600 per day. |
| Customer complaint resolution | Our expenses |
| Special evaluation fee | Currently $600, plus our out-of-pocket costs |
| Non-compliance cure costs and fee | Our out-of-pocket costs and internal cost allocation, plus 10% |
| Liquidated damages | An amount equal to royalty fees, marketing fund contributions, medical and scientific affairs support fees, and data targeting and reporting fees, for the lesser of (i) 2 years or (ii) the remaining months of the franchise term. |
| Indemnity | All of our costs and losses from any legal action related to the operation of your franchise |
| Prevailing party’s legal costs | Our attorney fees, court costs, and other expenses of a legal proceeding, if we are the prevailing party |
Training Program (Item 11)
| Detail | Information |
|---|---|
| Total Duration | 80 hours (32 classroom, 48 on-the-job) |
| Classroom Training | 32 |
| On-the-Job Training | 48 |
| Training Location | Our offices in Atlanta, GA or Remote Learning |
| Additional Training | If a manager or other employee is sent to training after opening, or if additional training (including onboarding) is requested, a then-current training fee (currently $750 per person per day) will be charged. Franchisees must pay travel and living expenses for attendees. |
Territory Rights (Item 12)
| Detail | Information |
|---|---|
| Territory Type | Protected |
| Exclusive Territory | Yes |
| Territory Size | approximately 450,000 to 750,000 people |
| Description | The territory boundaries are based on traditional pharmaceutical analytics and specified by zip codes, county or city lines, or other limits. The franchisor will not establish or license another Galt Pharmaceuticals outlet within the protected territory, nor license another party to establish one that serves customers in the territory. However, the franchisor and its affiliates retain the right to serve customers in the territory if the franchisee is in default or incapable of meeting demand, or to sell optional products/services if the franchisee declines to offer them. The franchisor may also operate businesses under different trademarks or channels of distribution that do not sell Galt Pharmaceutical brand products within the territory. |
Renewal, Termination & Transfer (Item 17)
| Detail | Information |
|---|---|
| Initial Term | 10 years |
| Renewal Term | up to one additional 10-year terms |
| Renewal Fee | One-half of our then-current initial franchise fee |
| Renewal Conditions | To renew, the franchisee must give 90-180 days advance notice, be in compliance with all contractual obligations, have been in substantial compliance throughout the term, conform the business to then-current System Standards, sign the then-current standard franchise agreement and related documents (which may have materially different terms and/or fees, but no new initial franchise fee), pay the renewal fee, and execute a general release. |
| Transfer Fee | $25,000, plus any broker fees and other out-of-pocket costs we incur |
| Transfer Conditions | Transfers require franchisor consent, which may be conditioned on: payment of a transfer fee ($25,000 plus broker/out-of-pocket costs), the proposed assignee meeting franchisor standards and being approved, the assignee not being a competitor, the assignee executing the then-current franchise agreement (without initial fee), all owners providing a guaranty, the franchisee having paid all monetary obligations and being in compliance, the assignee and owners/employees completing training, and the franchisee/owners/transferee executing a general release. The business must also comply with all most recent System Standards. |
| Termination for Cause | The franchisor may terminate for cause with a 10-day cure period for non-payment or insufficient funds. A 30-day cure period applies for other breaches. Termination without cure period can occur for misrepresentation, false information, bankruptcy, violation of law/confidentiality, failure to meet minimum sales quota more than once, uncured promissory note default, transfer restriction violation, slander/libel, refusal to cooperate with audit/evaluation, operating in a dangerous manner (if not corrected in 48 hours), cessation of operations for 5+ days, three defaults in 12 months, cross-termination, felony conviction/plea, or any act likely to materially affect the brand. |
| Non-Compete Period | Not applicable |
| Non-Compete Details | The franchise agreement states that non-competition covenants during the term of the franchise and after termination or expiration are 'Not applicable'. |
Operations & Supply (Items 8 & 15)
| Detail | Information |
|---|---|
| Owner-Operator Required | Yes |
| Participation Details | The franchisee is required to participate personally in the direct operation of the business and devote substantial time and attention to it. If the business is owned by an entity, a designated "Principal Executive" (who must own at least 25% of the business) is responsible for direct operation, decision-making, and completing initial and future training programs. The Principal Executive must also make reasonable efforts to attend all required in-person and remote meetings, not failing to attend more than three consecutive ones. |
| Required Suppliers | Franchisee must purchase or lease all goods, services, supplies, fixtures, equipment, inventory, computer hardware and software, real estate, or comparable items related to establishing or operating the business either from the franchisor or its designee, or from approved suppliers, or according to franchisor specifications. The franchisor and its affiliates (including GALTRX and Safer Pain) are currently the only authorized providers of marketing materials and GALTRX is the only authorized provider of GALTRX pharmaceutical samples. The franchisor reserves the right to be a supplier (or the sole supplier) of any other good or service in the future. |
| Supply Restrictions | Franchisee must use specified computer software and hardware. The franchisor is the only supplier of certain administrative services (quality assurance, billing, and collection). Franchisee must purchase or use approved marketing materials and GALTRX pharmaceutical samples. The franchisor and its affiliates are the exclusive suppliers of pharmaceuticals and marketing materials. Franchisees must obtain approval for alternative suppliers based on criteria such as capacity, quality, financial stability, reputation, reliability, inspections, product testing, and performance reviews. |
| Franchisor Revenue from Suppliers | The franchisor's revenue from all required purchases and leases of products and services by franchisees in the prior fiscal year (including marketing materials and supplies, print materials, and email/technology fees) was approximately $32,241, representing 0.9% of total revenues. The franchisor and GALTRX may derive revenue based on required franchisee purchases and may receive revenue from approved suppliers based on franchisee purchases. |
Financing (Item 10)
| Detail | Information |
|---|---|
| Financing Available | Yes |
| Description | The franchisor may offer partial financing of the Initial Franchise Fee to financially qualified franchisees, up to 50% of the fee, with a maximum of $100,000. A down payment of $75,000-$100,000 is required. The term is 48 months, with an interest rate equal to the Prime Rate (currently 8.25%) plus two percent (2%). There is no prepayment penalty. Personal Guaranty is required as security. Default consequences include the full amount of remaining principal and interest plus collection costs, and termination of the Franchise Agreement. |
Galt Pharmaceuticals Franchise Earnings — Item 19
Galt Pharmaceuticals does not make an Item 19 financial performance representation in their FDD. This means they do not disclose revenue, profit, or earnings data for franchised locations. Before investing, ask the franchisor directly for franchisee contact information so you can speak with existing owners about their actual financial performance.
Galt Pharmaceuticals does not include an Item 19 financial performance representation in their FDD. Contact information for current and former franchisees is listed in Item 20 of the FDD.
Galt Pharmaceuticals Litigation & Risk Flags
Clean Litigation RecordGalt Pharmaceuticals has no pending litigation actions listed in their FDD. There is also no bankruptcy history disclosed.
Litigation and bankruptcy data is sourced from Items 3 and 4 of the FDD. Always verify current status directly from the most recent FDD.
Galt Pharmaceuticals System Growth
Total Units
65
Franchised
65
Company-Owned
0
Galt Pharmaceuticals currently operates 65 franchised locations and 0 company-owned units. Unit count data is sourced from Item 20 of the FDD.
Unit History (Item 20)
| Year | Opened | Closed | Total |
|---|---|---|---|
| 2020 | 21 | 30 | 64 |
| 2021 | 3 | 3 | 64 |
| 2022 | 1 | 0 | 65 |
Transfers: 1 | Closures: 33
State Registrations
Registered in 15 states: CA, HI, IL, IN, MD, MI, MN, NY, ND, OR, RI, SD, VA, WA, WI
Franchisor Financials (Item 21)
Revenue
$2.6M
Net Income
$689K
Total Assets
$11.6M
Audited by Warren Averett, LLC for year ending December 31.
Galt Pharmaceuticals Franchise — FAQ
The total investment to open a Galt Pharmaceuticals franchise ranges from $219,950 to $242,200, per their Franchise Disclosure Document. This includes the initial franchise fee of $200,000. The investment covers build-out, inventory, equipment, signage, working capital, and other startup costs.
Galt Pharmaceuticals charges a royalty fee of 6% of your Total Sales Margins of gross sales, plus a 1% of Total Sales Margins contribution to the marketing/advertising fund. These fees are paid on an ongoing basis.
You can download the Galt Pharmaceuticals Franchise Disclosure Document free on this page. The FDD is a public document filed with state franchise registries. Always also request the current FDD directly from Galt Pharmaceuticals to ensure you have the most up-to-date version.
Galt Pharmaceuticals does not provide an Item 19 financial performance representation in their FDD, which means they do not disclose franchisee revenue or earnings data. Prospective investors should contact existing franchisees directly (listed in Item 20 of the FDD) to gather real-world financial performance information.
Galt Pharmaceuticals has been franchising since 2018. The FDD shows an investment range of $219,950-$242,200, a 6% of your Total Sales Margins royalty, and no Item 19 earnings disclosure. There is no pending litigation. Review the full FDD and contact current franchisees listed in Item 20 before making any investment decision.
The franchise fee is $200,000 and the total investment ranges from $219,950 to $242,200 depending on location size and market. Contact the franchisor directly for current net worth and liquid capital requirements, territory availability, and application details.
Similar Senior Care & Healthcare Franchises
Interested in Galt Pharmaceuticals?
Get free info on this franchise. We will send you a detailed FDD report by email.
Data Source & Disclaimer: This website is for informational purposes only. It is not an offer to sell or buy a franchise. This profile is based on publicly available FDD data sourced from state franchise registry filings. All information is for research purposes only and does not constitute legal, financial, or investment advice. Data may be outdated or contain errors. Always obtain the current FDD directly from Galt Pharmaceuticals and consult a qualified franchise attorney before making any investment decision. FranchiseOverview.com is operated by Franchising Compliance, LLC and is not affiliated with Galt Pharmaceuticals or any of its subsidiaries. To report an inaccuracy: info@franchiseoverview.com